Drexel Morgan & Co’s Gilead Sciences GILD Stock Holding History

Drexel Morgan & Co’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,871	Closed	-$473K	–	51
2021 Q2	$473K	Sell	6,871 -1,735	-20%	-$116K	0.14%	52
2021 Q1	$556K	Hold	8,606	–	–	0.14%	66
2020 Q4	$501K	Hold	8,606	–	–	0.14%	63
2020 Q3	$544K	Hold	8,606	–	–	0.19%	60
2020 Q2	$662K	Hold	8,606	–	–	0.25%	51
2020 Q1	$643K	Hold	8,606	–	–	0.25%	51
2019 Q4	$559K	Hold	8,606	–	–	0.42%	53
2019 Q3	$545K	Hold	8,606	–	–	0.42%	51
2019 Q2	$581K	Hold	8,606	–	–	0.45%	50
2019 Q1	$559K	Hold	8,606	–	–	0.5%	49
2018 Q4	$538K	Sell	8,606 -340	-4%	-$23.8K	0.54%	45
2018 Q3	$691K	Hold	8,946	–	–	0.61%	41
2018 Q2	$634K	Buy	+8,946	New	+$632K	0.63%	41
2017 Q2	–	Sell	-6,480	Closed	-$440K	–	91
2017 Q1	$440K	Sell	6,480 -1,000	-13%	-$70.3K	0.49%	52
2016 Q4	$536K	Buy	7,480 +2,000	+36%	+$149K	0.64%	48
2016 Q3	$434K	Sell	5,480 -2,000	-27%	-$162K	0.48%	55
2016 Q2	$624K	Buy	7,480 +2,000	+36%	+$177K	0.71%	48
2016 Q1	$503K	Hold	5,480	–	–	0.59%	52
2015 Q4	$555K	Buy	5,480 +1,365	+33%	+$142K	0.62%	52
2015 Q3	$404K	Sell	4,115 -520	-11%	-$57.8K	0.52%	58
2015 Q2	$543K	Sell	4,635 -1,397	-23%	-$153K	0.64%	47
2015 Q1	$592K	Buy	6,032 +320	+6%	+$32.5K	0.63%	50
2014 Q4	$538K	Hold	5,712	–	–	0.61%	50
2014 Q3	$608K	Hold	5,712	–	–	0.74%	43
2014 Q2	$474K	Hold	5,712	–	–	0.57%	51
2014 Q1	$405K	Buy	5,712 +80	+1%	+$6.27K	0.51%	52
2013 Q4	$423K	Hold	5,632	–	–	0.57%	48
2013 Q3	$354K	Hold	5,632	–	–	0.48%	54
2013 Q2	$289K	Buy	+5,632	New	+$294K	0.48%	64

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Drexel Morgan & Co's GILD Position: Q3 2021 in Review

Drexel Morgan & Co sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 6,871 shares — an estimated $473K sold.

Drexel Morgan & Co first reported a position in GILD in Q2 2013 and held it in 29 quarters. The position peaked at $691K in Q3 2018. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

Drexel Morgan & Co reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
Drexel Morgan & Co sold 6,871 Gilead Sciences shares in Q3 2021, an estimated $473K.
Drexel Morgan & Co first reported a position in Gilead Sciences in Q2 2013 and held it in 29 quarters.
Drexel Morgan & Co's Gilead Sciences position peaked at $691K in Q3 2018.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Drexel Morgan & Co's 13F filing for Q3 2021, filed 12 Nov 2021.